JNJ Johnson & Johnson
Price (delayed)
$157.71
Market cap
$379.71B
P/E Ratio
27.01
Dividend/share
$4.96
EPS
$5.84
Enterprise value
$392.23B
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
The gross profit is up by 4.7% YoY
JNJ's equity is up by 3.9% year-on-year
The quick ratio has increased by 11% QoQ but it has decreased by 4.9% YoY
Johnson & Johnson's net income has shrunk by 60% YoY and by 4.2% QoQ
The EPS has plunged by 58% YoY and by 3.2% from the previous quarter
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$379.71B
Enterprise value
$392.23B
Price to earnings (P/E)
27.01
Price to book (P/B)
5.31
Price to sales (P/S)
4.27
EV/EBIT
22.49
EV/EBITDA
15.83
EV/Sales
4.42
Revenue
$88.82B
Gross profit
$61.35B
Operating income
$20.8B
Net income
$14.07B
EBIT
$17.44B
EBITDA
$24.78B
Free cash flow
$19.84B
Per share
Balance sheet
Liquidity
EPS
$5.84
EPS diluted
$5.79
Free cash flow per share
$8.24
Book value per share
$29.69
Revenue per share
$36.9
TBVPS
$40.83
Total assets
$180.1B
Total liabilities
$108.61B
Debt
$36.63B
Equity
$71.49B
Working capital
$5.57B
Debt to equity
0.51
Current ratio
1.11
Quick ratio
0.78
Net debt/EBITDA
0.51
Margins
Efficiency
Dividend
EBITDA margin
27.9%
Gross margin
69.1%
Net margin
15.8%
Operating margin
23.4%
Return on assets
7.9%
Return on equity
19.9%
Return on invested capital
29.2%
Return on capital employed
13.4%
Return on sales
19.6%
Dividend yield
3.15%
DPS
$4.96
Payout ratio
84.9%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
0.5%
1 week
2.66%
1 month
-3.62%
1 year
5.76%
YTD
9.05%
QTD
-4.9%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$88.82B
Gross profit
$61.35B
Operating income
$20.8B
Net income
$14.07B
Gross margin
69.1%
Net margin
15.8%
Johnson & Johnson's net margin has plunged by 62% YoY and by 5% from the previous quarter
Johnson & Johnson's net income has shrunk by 60% YoY and by 4.2% QoQ
Johnson & Johnson's operating margin has decreased by 6% YoY and by 4.1% from the previous quarter
The gross profit is up by 4.7% YoY
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
27.01
P/B
5.31
P/S
4.27
EV/EBIT
22.49
EV/EBITDA
15.83
EV/Sales
4.42
The EPS has plunged by 58% YoY and by 3.2% from the previous quarter
JNJ's price to earnings (P/E) is 50% higher than its last 4 quarters average of 17.9 and 19% higher than its 5-year quarterly average of 22.6
JNJ's price to book (P/B) is 9% less than its 5-year quarterly average of 5.8
JNJ's equity is up by 3.9% year-on-year
The price to sales (P/S) is 15% less than the 5-year quarterly average of 5.0
JNJ's revenue is up by 4.3% year-on-year
Efficiency
How efficient is Johnson & Johnson business performance
The company's return on equity has shrunk by 60% YoY and by 4.8% QoQ
The return on assets has dropped by 59% year-on-year and by 6% since the previous quarter
The ROS has plunged by 56% YoY and by 6% from the previous quarter
Johnson & Johnson's return on invested capital has shrunk by 50% YoY and by 6% QoQ
Dividends
What is JNJ's dividend history
DPS
$4.96
Dividend yield
3.15%
Payout ratio
84.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 66% greater than its total liabilities
The quick ratio has increased by 11% QoQ but it has decreased by 4.9% YoY
Johnson & Johnson's total liabilities has increased by 10% YoY
Johnson & Johnson's debt is 49% less than its equity
Johnson & Johnson's debt has increased by 25% YoY and by 2.5% from the previous quarter
The company's debt to equity rose by 19% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.